Navigation Links
Genomic Health Announces Third Quarter 2009 Financial Results and Business Progress
Date:11/4/2009

ania, centered on the need for individualized cancer treatment and his experience in both breast and colon cancer.

To access the live and subsequently archived webcast of the analyst day presentation, visit the Investor Relations section of Genomic Health's website at http://investor.genomichealth.com. Please connect to the website at least 15 minutes prior to the beginning of the presentation to allow for any necessary software downloads. An archived replay will be available beginning 24 hours after the live presentation.

About Genomic Health

Genomic Health, Inc. (NASDAQ: GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched the Oncotype DX® breast cancer test, which has been shown to predict the likelihood of chemotherapy benefit as well as recurrence in early-stage breast cancer. In addition to the widely adopted Oncotype DX breast cancer test, Genomic Health is preparing to launch its Oncotype DX colon cancer test in early 2010. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit www.genomichealth.com

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to the company's ability to strengthen its business through continued investment in the worldwide expansion of its Oncotype DX breast cancer test and its launch of a colon cancer test; the company's expectation
'/>"/>

SOURCE Genomic Health, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Microarray provides 3 genomic guides to breast cancer treatment decisions
3. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
4. Genomic Health to Present at ThinkEquity Partners Fifth Annual Growth Conference
5. Genomic profiling of lung tumors helps doctors choose most effective treatment
6. Genomic technologies to identify toxic chemicals should be developed
7. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
8. Genomic Health Reports Inclusion of Oncotype DX(TM) in American Society of Clinical Oncology Guidelines
9. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
10. Millennium Announces MLN1202 Significantly Reduced Marker of Systemic Inflammation and Identifies Genomic Biomarker For Responders
11. Genomic Health to Present at JMP Securities Healthcare Focus Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., KELOWNA, BC, Nov. 27 /PRNewswire/ - Uploadable U...ng prime time in wellness. A combination of advanc...upload are solving a long term concern over the ac... accurately gauge and reward improved participatio...ies is one of the first wellness suppliers to inte...
(Date:11/27/2009)..., SAN FRANCISCO, Nov. 27 ...ed that Blair Lambert, CFO/COO, will present at th...held at the May Fair Hotel in London, England, on ..., To listen to a live broadcast of The Gymboree ...se log on to www.gymboree.com, click on "Our Compa...
(Date:11/27/2009)..., KIBBUTZ SHAMIR, Israel, Nov. 27 /PRNewswire-Firs...HMR ) ( "Shamir" ), a leading provider of innovati...market, announced today that its board of director...gate amount of US$ 10 million (approximately NIS 3...entative rate of exchange), or approximately US$ 0...
(Date:11/27/2009)...ates to bring unprecedented medical, economic burd...(HealthDay News) -- The number of people with diab...er the next 25 years, a new study predicts. , T...llion people with the disease, up from 23.7 millio...ing people with diabetes will triple, the study al...
(Date:11/27/2009)... Multi-purpose bilingual coloring ... for use by the business community to educate - in...bjects from Safety issues to Dinosuars to ABC,S an... Saint Louis, MO (PRWEB) November 27, 2009 -- To...ics or toys to keep them busy any hour of the day,...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
...e for its smartTOUCH(R),product line, JERICHO, N....RX) today announced that it has signed a three yea...andyman service, Mr.,Handyman, to provide its cust...rmostats, mailboxes and more., "As our company in...
...reatment Cleared for,Patients Who Have Not Benefit...Pa., Oct. 8 Neuronetics, Inc., a,privately-held m...,neuromodulation, announced today that the U.S. Fo...roStar TMS Therapy(R) is,specifically indicated fo...
...w.ilcdover.com ),the company that manufactures spa...premium line of aesthetically pleasing head covers...roduct is the direct result,of feedback from healt...bin/prnh/20081008/NEW027 ), The new printed head...
..., but all,the money you,re spending on gifts for f...erry. Don,t let yourself fall into the trap of hol...gation. Take the following,simple measures to prev...ck it twice -- planning a realistic budget ahead,o...
...sociation (DIA) will host the 6th Canadian Annual ... discuss a number of important issues facing Healt...emia, and the health care system. , ...g/diahome/FlagshipMeetings/home.aspx?meetingid=171...
...North America) announced today the extension of it...., a leading nanotechnology co-development company...Business Wire EON) October 7, 2008 -- The origina... materials. , , , After successfully meeting initi...
Other Medicine News:Health News:bioMETRX Teams Up With Mr. Handyman 2Health News:bioMETRX Teams Up With Mr. Handyman 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 2Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 3Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 4Health News:FDA Clears NeuroStar(R) TMS Therapy for the Treatment of Depression 5Health News:ILC Dover Introduces 'Patient Friendly' Respiratory Protection for Health Care Market 2Health News:Holiday Gift Giving: How You and Your Budget can Survive the Season 2Health News:DIA 6th Canadian Annual Meeting Benefit and Risk Management: An Evolution in Progress 2Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 2Health News: Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance 3
(Date:11/25/2009)... , WESTON, Fla., Nov. 25 /PRNewswire-FirstC...heets: ASFX) ("the Company") is pleased to announc...roduction management office in Shanghai, China. ,... providing an essential gateway for the developmen...safety products for children and adults to be dist...
(Date:11/25/2009)... , PHILADELPHIA, Nov. 25 /PRNewswire-FirstCa...Dr. Michael J. McKelvey, the Company,s President a... Vice President and CFO, are scheduled to present ...rence at 1:30 PM EST on December 1, 2009 in New Yo...cess the presentation by visiting the Company,s co...
(Date:11/25/2009)... , WEST PALM BEACH, Fla., Nov. 25 /PRNewswire-F...mpaired Americans, especially the 27 million livin...not be all that happy, says audiologist Cindy Beye...SA (Amex: EAR ), one of America,s largest hearing...ave linked hearing loss to stress, frustration, an...
Breaking Medicine Technology:American Scientific Resources Inc. Opens Shanghai Location 2ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 2For Millions With Untreated Hearing Loss, Holiday Season Can be Especially Difficult 3Amalgamated Capital Serves as Syndication Agent in the Recapitalization of 180 Medical Inc 61086 1Amalgamated Capital Serves as Syndication Agent in the Recapitalization of 180 Medical Inc 61086 2Amalgamated Capital Serves as Syndication Agent in the Recapitalization of 180 Medical Inc 61086 3Amalgamated Capital Serves as Syndication Agent in the Recapitalization of 180 Medical Inc 61086 4Faith Based Investors Press Dozens of Top Companies to Say If U S Chamber of Commerce Speaks for Them in Opposing Health Care Reform 61084 1Faith Based Investors Press Dozens of Top Companies to Say If U S Chamber of Commerce Speaks for Them in Opposing Health Care Reform 61084 2Faith Based Investors Press Dozens of Top Companies to Say If U S Chamber of Commerce Speaks for Them in Opposing Health Care Reform 61084 3Faith Based Investors Press Dozens of Top Companies to Say If U S Chamber of Commerce Speaks for Them in Opposing Health Care Reform 61084 4Faith Based Investors Press Dozens of Top Companies to Say If U S Chamber of Commerce Speaks for Them in Opposing Health Care Reform 61084 5Faith Based Investors Press Dozens of Top Companies to Say If U S Chamber of Commerce Speaks for Them in Opposing Health Care Reform 61084 6Reportlinker Adds North America Negative Pressure Wound Therapy 28NPWT 29 Market 3A Strategic Market Analysis and Insight to 2012 61082 1Reportlinker Adds North America Negative Pressure Wound Therapy 28NPWT 29 Market 3A Strategic Market Analysis and Insight to 2012 61082 2Reportlinker Adds North America Negative Pressure Wound Therapy 28NPWT 29 Market 3A Strategic Market Analysis and Insight to 2012 61082 3Reportlinker Adds North America Negative Pressure Wound Therapy 28NPWT 29 Market 3A Strategic Market Analysis and Insight to 2012 61082 4Reportlinker Adds North America Negative Pressure Wound Therapy 28NPWT 29 Market 3A Strategic Market Analysis and Insight to 2012 61082 5
...E)--May 23, 2007 - CytoGenix, Inc. (CYGX.OB),annou...icer will,present an update on preclinical animal ...prietary synDNA(TM) technology at the 2007,DNA Vac...en May 23,and May 25., Dr. Chen comments, "We have...vaccines in mice, rabbits and non-human primates.,...
... symptoms and urine flow over 28-week period, QUEB...erna,Zentaris Inc. , a global biopharmaceutical co...oday announced that its partner,Spectrum Pharmaceu...ase 2 results for AEterna Zentaris, fourth-generat...RH) antagonist, ozarelix, in,benign prostatic hype...
Other Medicine Technology:CytoGenix to Present at 2007 International DNA Vaccines Conference,in Spain 2AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 2AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 3AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 4AEterna Zentaris' Partner, Spectrum, Discloses Detailed Phase 2,Data for Ozarelix, in BPH at Annual AUA Meeting 5
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
...oratory and a worldwide leader in innovative labor...ensive test menu of highly complex and unique medi...d by the University of Utah, ARUP Laboratories' cl...rsity teaching hospitals and children's hospitals,...
Medicine Products: